Ascendis Pharma A (ASND) Capital Expenditures (2014 - 2024)
Ascendis Pharma A (ASND) recorded Capital Expenditures of $1.08 million in the quarter ended Dec 31, 2024, down 60.0% from $2.7 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Capital Expenditures (2014 - 2024) Analysis & Trends
On a TTM basis, Ascendis Pharma A's Capital Expenditures came in at -$20,206 as of Dec 31, 2024; for the year ended Dec 31, 2022, it came in at $10.05 million.
- Across earlier years, Capital Expenditures came in at -$23.68 million in the year ended Dec 31, 2020, -$5.71 million in the year ended Dec 31, 2019 and -$3.13 million in the year ended Dec 31, 2018.
- Quarterly Capital Expenditures has ranged from -$13.33 million in the quarter ended Sep 30, 2021 to $21.63 million in the quarter ended Dec 31, 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$512,869 (quarter ended Sep 30, 2024), -$368,296 (quarter ended Jun 30, 2024) and -$216,186 (quarter ended Mar 31, 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Ascendis Pharma A | 14.48 Bn | 10.74 Bn | 362.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 512,868.51 |
| Jun 30, 2024 | 368,295.55 |
| Mar 31, 2024 | 216,185.99 |
| Dec 31, 2023 | -67,784.21 |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 483,482.43 |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 4.29 Mn |
| Dec 31, 2021 | 5.49 Mn |
| Sep 30, 2021 | 13.33 Mn |
| Jun 30, 2021 | 4.31 Mn |
| Mar 31, 2021 | 4.86 Mn |
| Dec 31, 2020 | 5.08 Mn |
| Sep 30, 2020 | 5.69 Mn |
| Jun 30, 2020 | 5.05 Mn |
| Mar 31, 2020 | 6.78 Mn |
| Dec 31, 2019 | 1.25 Mn |
API Access
Ascendis Pharma A Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();